Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-07

Clinical Trial Update: The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dapagliflozin, metformin, and physical activity in prediabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)
  • metformin (metformin)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Prediabetic State, Obesity | Phase 2 | Status: COMPLETED